Anti-Human CD140a Recombinant Antibody(Tovetumab)

Name: Anti-Human CD140a Recombinant Antibody(Tovetumab)
Brand: KMD Bioscience
SKU: YR1314

YR1314

科研级 Tovetumab ( 托维妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Tovetumab

DATASHEET MSDS

Product Description

Alias	科研级 Tovetumab ( 托维妥单抗 ), Anti-CD140a Recombinant Antibody, Research Grade Tovetumab
Catalog Number	YR1314
Molecular Name	Tovetumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Tovetumab is an anti-PDGFRa monoclonal antibody designed for the treatment of cancer. It was developed by MedImmune, and trialed for use in glioblastoma and non-small cell lung cancer. Development was discontinued in 2013. This drug was developed by MedImmune, LLC.
CAS Number	1243266-04-7
Application	IP, IF, FuncS, FCM, Neut, ELISA, ICC
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD140a[Homo sapiens]

Login